Major disruptions of sleep during treatment of the opiate withdrawal syndrome: Differences between methadone and lofexidine detoxification treatments

Addiction Biology

Volumn 8, Issue 1, 2003, Pages 49-57

  Beswick, Tracy ^a   Best, David ^a,b   Rees, Sian ^a   Bearn, Jenny ^a   Gossop, Michael ^a   Strang, John ^a  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LOFEXIDINE; METHADONE;

ABSTINENCE; ADULT; ARTICLE; DETOXIFICATION; DRUG DEPENDENCE; DRUG EFFECT; EXPERIENCE; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PRIORITY JOURNAL; RATING SCALE; RISK BENEFIT ANALYSIS; SELF REPORT; SLEEP DISORDER; WAKEFULNESS; WITHDRAWAL SYNDROME;

CLONIDINE; HUMANS; METHADONE; NARCOTIC ANTAGONISTS; NARCOTICS; SLEEP DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 0037360898     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/1355621031000069882     Document Type: Article

References (36)

1. Gossop M, Griffiths P, Bradley B, Strang J. Opiate withdrawal symptoms in response to 10-day and 21-day methadone withdrawal programmes. Br J Psychiatry 1989;154:360-3.
2. Bearn J, Gossop M, Strang J. Randomised double-blind comparison of lofexidine and methadone in the inpatient treatment of opiate withdrawal. Drug Alcohol Depend 1996;43:87-9.
3. Bearn J, Gossop M, Strang J. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for inpatient opiate detoxification. Drug Alcohol Depend 1998;50:227-32.
4. Merrill J, Marshall R. Opioid detoxification using naloxone. Drug Alcohol Rev 1997;16:3-6.
5. Buntwal N, Bearn J, Gossop M, Strang J. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for inpatient detoxification. Drug Alcohol Depend 2000;59:183-8.
6. Beswick T, Best D, Bearn J, Gossop M, Rees S, Strang J. The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomised and placebo-controlled trial. Am J Addict in press.
7. Lewis S, Oswald I, Evans J, Akindele M, Tompsett S. Heroin and human sleep. Electroencephalogr Clin Neurophysiol 1970;28:374-81.
8. Goodman L, Gilman A. Goodman and Gilman's The pharmacological basis of therapeutics. New York: Macmillan Publishing Co, 1980.
9. Kay D, Pickworth W, Neidert G. Morphine-like insomnia from heroin in non-dependent human addicts. Br J Clin Pharmacol 1980;11:159-69.
10. Orr W, Srahl M. Sleep patterns in human methadone addiction. Br J Addict 1978;73:311-5.
11. Rogalski C, Lahmeyer H. Effect of the hypnotic flurazepam on the sleep of pentazocine and heroin addicts during withdrawal. Int J Addict 1983;18:407-18.
12. Gossop M, Bradley B. Insomnia among addicts during supervised withdrawal from opiates: a comparison of oral methadone and electro-stimulation. Drug Alcohol Depend 1984;13:191-8.
13. Mellinger G, Balter M, Uhlenhuth E. Insomnia and its treatment: prevalence and correlates. Arch Gen Psych 1985;42:225-32.
14. Lukas S, Dorsey C, Mello N, et al. Reversal of sleep disturbances in cocaine-and heroin-dependent men during chronic buprenorphine treatment. Exp Clin Psych 1996;4:413-20.
15. Kleber H. Detoxification from narcotics. In: Lowinson J, Ruiz P, editors. Substance abuse. Baltimore: Williams and Wilkins, 1981, pp. 317-38.
16. Oyefeso A, Sedgewick P, Ghodse H. Subjective sleep-wake parameters in treatment-seeking opiate addicts. Drug Alcohol Depend 1997;48:9-16.
17. Kay DC, Samuiddin Z. Sleep disorders associated with drug abuse and drugs of abuse. In: Williams RL, Karacan I, Moore CA, editors. Sleep disorders diagnosis and treatment. New York: John Wiley, 1988, pp. 315-63.
18. Kay D. Human sleep and EEG through a cycle of methadone dependence. Electroencephalogr Clin Neurophysiol 1994;38:35-43.
19. Howe R, Hegge F, Philips J. Acute heroin abstinence in man. Changes in behaviour and sleep. Drug Alcohol Depend 1980;5:341-56.
20. Gossop M. The development of a short opiate withdrawal scale (SOWS). Addict Behav 1990;15:487-90.
21. Marsden J, Gossop M, Stewart D, et al. The Maudsley Addiction Profile (MAP); a brief instrument for assessing treatment outcome. Addiction 1998;93:1857-68.
22. Gold M, Potash C, Sweeney D, Kleber H. Opiate detoxification with lofexidine. Drug Alcohol Depend 1981;8:307-15.
23. Nicholson A, Bradley C, Pascoe P. Medications: effect on sleep and wakefulness. In: Kruger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. Philadelphia: WB Saunders and Co, 2000, pp. 364-72.
24. Cohen M, Stimmel B. The use of methadone in narcotic dependency. In: Schecter A, editor. Treatment aspects of drug dependency. West Palm Beach, FL: CRC Press 1978, pp. 1-31.
25. Law F, Wilson S, Melichar J, Nutt D, Myles J. Objective actigraphic measurement of the effect of hypnotics during lofexidine assisted methadone withdrawal. NIDA Res Monogr Series 1997;78:307.
26. Soldatos C. Insomnia in relation to depression and anxiety: epidemiological considerations. J Psychosom Res 1994;38:3-8.
27. Ford D, Kamerow D. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportrinity for prevention?. JAMA 1981;262:1479-84.
28. Edinger J, Fins A. The distribution and clinical significance of sleep time misperceptions among insomniacs. Sleep 1995;18:232-9.
29. Anglin MD, Hser YI. Legal coercion and drug abuse treatment. In: Inciardi J, editor. Handbook on drug control in the United States. Westport, CT: Greenwood Press, 1990, pp. 151-76.
30. Simpson D, Joe G, Broome K, Hiller M, Knight K, Rowan-Szal G. Program diversity and treatment retention rates in drug abuse treatment outcome study (DATOS). Psychol Addict Behav 1997;11:279-93.
31. Gossop M, Marsden J, Stewart D, Rolfe A. Treatment retention and one year outcomes for residential programmes in England. Drug Alcohol Depend 1999;57:89-98.
32. Skoloda T, Alterman A, Gottheil E. Sleep quality reported by drinking and non-drinking alcoholics. In: E. Elmsford GE, editor. Addiction research and treatment: converging trends. New York: Pergamon Press, 1979, pp. 102-12.
33. Foster J, Powell J, Marshall J, Peters T. Quality of life in alcohol dependent subjects: a review. Qual Life Res 1999;8:255-61.
34. Brower K, Aldrich M, Hall J. Polysomnographic and subjective sleep predictors of alcoholic relapse. Alcohol Clin Exp Res 1998;22:1864-71.
35. Drummond SP, Gillin JC, Smith TL, DeModena A. The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res 1998;22:1796-802.
36. Brower KJ, Aldrich MS, Robinson EA, Zucker RA, Greden JF. Insomnia, Self-medication, and relapse to alcoholism. Am J Psychiatry 2001;158:399-404.